(Q33897492)

29 July 2017

title

Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs (English)

1 reference

29 July 2017

7

Erkki Ruoslahti

1 reference

29 July 2017

Kazuki N Sugahara

1

1 reference

29 July 2017

Tambet Teesalu

2

1 reference

29 July 2017

Priya Prakash Karmali

3

1 reference

29 July 2017

Venkata Ramana Kotamraju

4

1 reference

29 July 2017

Lilach Agemy

5

1 reference

29 July 2017

Daniel R Greenwald

6

1 reference

29 July 2017

language of work or name

English

0 references

publication date

8 April 2010

1 reference

29 July 2017

1 reference

29 July 2017

volume

328

1 reference

29 July 2017

issue

5981

1 reference

29 July 2017

page(s)

1031-1035

1 reference

Integrins in cancer: biological implications and therapeutic opportunities

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2881692

Tissue-penetrating delivery of compounds and nanoparticles into tumors

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2881692

C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2881692

Systematic surface engineering of magnetic nanoworms for in vivo tumor targeting

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2881692

Enhanced antitumor efficacy of clinical-grade vasculature-targeted liposomal doxorubicin

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2881692

Targeting of albumin-embedded paclitaxel nanoparticles to tumors

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2881692

The role of doxorubicin and epirubicin in the treatment of patients with metastatic hormone-refractory prostate cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2881692

Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2881692

Neuropilins: structure, function and role in disease.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2881692

Semaphorin 3A suppresses VEGF-mediated angiogenesis yet acts as a vascular permeability factor

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2881692

Drug penetration in solid tumours

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2881692

Applications of major histocompatibility complex class I molecules expressed as single chains

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2881692

Modulation of brain tumor capillaries for enhanced drug delivery selectively to brain tumor

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2881692

Stage-specific vascular markers revealed by phage display in a mouse model of pancreatic islet tumorigenesis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2881692

Progressive vascular changes in a transgenic mouse model of squamous cell carcinoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2881692

Vascular permeability enhancement in solid tumor: various factors, mechanisms involved and its implications

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2881692

Specialization of tumour vasculature

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2881692

A tumor-homing peptide with a targeting specificity related to lymphatic vessels

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2881692

A fragment of the HMGN2 protein homes to the nuclei of tumor cells and tumor endothelial cells in vivo

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2881692

Phage libraries displaying cyclic peptides with different ring sizes: ligand specificities of the RGD-directed integrins

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2881692

Selection of peptides binding to the alpha 5 beta 1 integrin from phage display library.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2881692

Characterization of murine monoclonal antibodies reactive to either the human epidermal growth factor receptor or HER2/neu gene product

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2881692

Humanization of an anti-p185HER2 antibody for human cancer therapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2881692

An optimized Alu-PCR primer pair for human-specific amplification of YACs and somatic cell hybrids

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2881692

Is anticancer drug development heading in the right direction?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2881692

Augmentation of transvascular transport of macromolecules and nanoparticles in tumors using vascular endothelial growth factor.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2881692

Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2881692

Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin

29 October 2018

1 reference

12 December 2020

Acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis

1 reference

12 December 2020

Vascular reactions to histamine, histamine-liberator and leukotaxine in the skin of guinea-pigs

1 reference

12 December 2020

Characterization of a Bicyclic Peptide Neuropilin-1 (NP-1) Antagonist (EG3287) Reveals Importance of Vascular Endothelial Growth Factor Exon 8 for NP-1 Binding and Role of NP-1 in KDR Signaling

1 reference

12 December 2020

Identifiers

DOI

10.1126/SCIENCE.1183057

1 reference

29 July 2017

1 reference

29 July 2017

1 reference